ALLO vs MSFT: Which Stock is Better?
Side-by-side comparison of Allogene Therapeutics Inc and Microsoft Corporation in 2026
ALLO
Allogene Therapeutics Inc
$1.99
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | ALLO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $258.10M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | ALLO |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | -100.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze ALLO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALLO or MSFT a better investment?
Comparing ALLO and MSFT: Allogene Therapeutics Inc has a market cap of $258.10M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALLO and MSFT?
ALLO (Allogene Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALLO or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALLO or MSFT?
MSFT has higher revenue growth at 18.4% vs -100.0% for ALLO.
Which company is more profitable: ALLO or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for ALLO.
Which is the larger company: ALLO or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $258.10M for ALLO.
Should I buy ALLO or MSFT in 2026?
Both ALLO and MSFT have investment merit. ALLO trades at $1.99 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALLO and MSFT stock?
Key differences: Market Cap ($258.10M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (-100.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy ALLO or MSFT in 2026?
The choice between ALLO and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ALLO and MSFT?
ALLO (Allogene Therapeutics Inc) has a market cap of $258.10M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.